Seeking new methods to treat heroin addiction

September 26, 2013 by Elin Fugelsnes

"Heroin itself is an inactive substance," explains Jørg Mørland, Norwegian forensic medicine and toxicology researcher. "The substances that heroin forms in the body are mainly what enter the brain and cause the narcotic effects."

The heroin high and feelings of manifest themselves almost immediately after the drug has been injected. Yet it was shown many years ago that heroin is inactive at the in the .

So what is it about heroin that brings about such a pronounced effect? A number of research projects funded under the Programme on Alcohol and Drug Research (RUSMIDDEL) at the Research Council of Norway may help to solve the mystery.

"Gaining a thorough understanding of the effects of heroin and of the involved will be a valuable basis for the development of new treatments for addiction," states Jørg Mørland, who is the project manager of an ongoing project on this important subject, the most recent in a long line of such Norwegian projects which he has headed.

Dr Mørland is a senior researcher at the Norwegian Institute of Public Health and Professor emeritus at the University of Oslo. Through studies on and mice, he and his colleagues have come up with new findings that may be significant to the development of new treatment methods.

Heroin metabolises rapidly

One widely-held theory has been that heroin passes quickly into the brain where it is converted into morphine, and that what users are actually experiencing are the effects of morphine. As it turns out, however, heroin undergoes a number of important transformations on its way to the brain. Just a few minutes after injection, the conversion of heroin into the metabolite 6-MAM is almost complete.

"Our research shows that it is primarily 6-MAM that crosses the blood-brain barrier and that heroin as such only enters the brain to a small degree. Thirty minutes after injecting heroin, 6-MAM is the predominant substance both in the blood and in the brain," Dr Mørland explains.

The presence of 6-MAM also results in a sharp increase in the signalling molecule, dopamine, in certain areas of the brain. This plays a pivotal role in the rewarding effect.

"This points towards 6-MAM as the main substance behind all the acute effects of heroin," says Dr Mørland.

"After about an hour, most of the 6-MAM has been converted into morphine. Morphine acts rapidly on the body and is the dominant component for the next hours, but from six to twelve hours after injection the effects observed are mostly consequences of a formed from , morphin-6-glucuronide.

Looking for a new treatment

"We are working to understand the roles of all these metabolites and to investigate potential treatments to counter their effects," Dr Mørland states.

The current approach to treating heroin addiction in Norway is pharmacotherapy – using methadone, subutex or subuxone. These are synthetic substances that all work in the same way as heroin, however, and are addictive in their own right.

"The treatment method involves administering these substances over the course of a day to reduce the rewarding effect. The intent is to diminish the patient's preoccupation with finding heroin in order to lead a more normal life," Dr Mørland points out.

Researchers at the Norwegian Centre for Addiction Research (SERAF) in Oslo are examining sustained-release naltrexone – a non-addictive opioid antagonist that blocks the effects of opiates in the brain. Dr Mørland is hopeful that his research will make it possible to affect opiates even before they reach the brain.

An opiate roadblock

"It may be possible to block these substances from ever entering the brain, thereby modifying the effect of heroin," Dr Mørland adds.

As part of a new project, he and his colleagues will study the effect of a 6-MAM antibody developed by a Norwegian company. The antibody binds to the 6-MAM in the blood, making the 6-MAM molecule too large to cross the blood-brain barrier.

"If we succeed in getting this antibody to work it could block much – and maybe even all – of the effect of ," the concludes.

Explore further: Scientists can now block heroin, morphine addiction; clinical trials possible within 18 months

Related Stories

Long-term methadone treatment can affect nerve cells in brain

August 15, 2012

Long-term methadone treatment can cause changes in the brain, according to recent studies from the Norwegian Institute of Public Health. The results show that treatment may affect the nerve cells in the brain. The studies ...

Heroin vaccine blocks relapse in preclinical study

May 6, 2013

Scientists at The Scripps Research Institute (TSRI) have reported successful preclinical tests of a new vaccine against heroin. The vaccine targets heroin and its psychoactive breakdown products in the bloodstream, preventing ...

Recommended for you

Young adults found displaying symptoms of net addiction

October 17, 2014

In 2012, Allen Frances, MD, professor emeritus and former chair of the department of psychiatry at Duke University, cautioned that "Internet Addiction" could be the next new fad diagnosis, complete with "an exuberant trumpeting ...

Can 'love hormone' oxytocin protect against addiction?

March 19, 2014

(Medical Xpress)—Researchers at the University of Adelaide say addictive behaviour such as drug and alcohol abuse could be associated with poor development of the so-called "love hormone" system in our bodies during early ...

Nicotine vaccine prevents nicotine from reaching the brain

May 2, 2012

If smoking a cigarette no longer delivers pleasure, will smokers quit? It's the idea behind a nicotine vaccine being created by MIT and Harvard researchers, in which an injection of synthetic nanoparticles prompts the immune ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.